Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $24.8000 (-6.42%) ($24.8000 - $26.5000) on Mon. Dec. 23, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1029.69% (three month average) | RSI | 58 | Latest Price | $24.8000(-6.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) IWM(7%) JNK(7%) PEJ(7%) EEM(6%) | Factors Impacting CAPR price | CAPR will decline at least -514.845% in a week (0% probabilities). TLT(-3%) XBI(-2%) UUP(-2%) UNG(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -514.845% (StdDev 1029.69%) | Hourly BBV | 0 () | Intraday Trend | -6.4% | | | |
|
Resistance Level | $26.46 | 5 Day Moving Average | $26.82(-7.53%) | 10 Day Moving Average | $26.41(-6.1%) | 20 Day Moving Average | $26.46(-6.27%) | To recent high | -46.7% | To recent low | 10.2% | Market Cap | $488m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |